CN Patent

CN102596250A — 治疗肠易激综合征(ibs)的方法

Assigned to Salix Pharmaceuticals Ltd · Expires 2012-07-18 · 14y expired

What this patent protects

本发明提供了新的方法和试剂盒，其用于治疗IBS、治疗女性中的IBS、治疗老年受试者中的IBS和治疗非白种人受试者中的IBS。

USPTO Abstract

本发明提供了新的方法和试剂盒，其用于治疗IBS、治疗女性中的IBS、治疗老年受试者中的IBS和治疗非白种人受试者中的IBS。

Drugs covered by this patent

Xifaxan (rifaximin) · Bausch Health

Patent Metadata

Patent number: CN102596250A
Jurisdiction: CN
Classification: —
Expires: 2012-07-18
Drug substance claim: No
Drug product claim: No
Assignee: Salix Pharmaceuticals Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.